Implementation Guide CH VACD
5.0.0-ci-build - ci-build Switzerland flag

Implementation Guide CH VACD, published by HL7 Switzerland. This guide is not an authorized publication; it is the continuous build for version 5.0.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7ch/ch-vacd/ and changes regularly. See the Directory of published versions

Example Bundle: Test Case C 01: Patient Dokument (C_D1_P_C1)

Document Details

Generated Narrative: Bundle Immunization Administration

Document Subject

Unable to resolve subject ''


Document Content

Immunization Administration

Id: C-D1-P-C1-Composition

Identifier: urn:ietf:rfc:3986#urn:uuid:fc215e64-c4f4-4e39-b751-f967b84cf106

Status: Final

Code: Immunization record (http://snomed.info/sct#41000179103)

Patient: Patient/TC-patient Wegmueller Monika

Date: June 15, 2021

Authors:

Patient/TC-patient Wegmueller Monika

Confidentiality: null Normal (qualifier value) (http://snomed.info/sct#17621005)

Sections:

Immunization Administration
Comments

Immunization Administration

Code: Hx of Immunization (http://loinc.org#11369-6)

Entries:

Immunization/TCC01-IMMUN1-patient

Comments

Code: Annotation comment [Interpretation] Narrative (http://loinc.org#48767-8)


Additional Resources Included in Document


Entry 1 - fullUrl = http://test.fhir.ch/r4/Composition/C-D1-P-C1-Composition

Resource Composition:

Immunization Administration

Id: C-D1-P-C1-Composition

Identifier: urn:ietf:rfc:3986#urn:uuid:fc215e64-c4f4-4e39-b751-f967b84cf106

Status: Final

Code: Immunization record (http://snomed.info/sct#41000179103)

Patient: Patient/TC-patient Wegmueller Monika

Date: June 15, 2021

Authors:

Patient/TC-patient Wegmueller Monika

Confidentiality: null Normal (qualifier value) (http://snomed.info/sct#17621005)

Sections:

Immunization Administration
Comments

Entry 2 - fullUrl = http://test.fhir.ch/r4/Patient/TC-patient

Resource Patient:

Generated Narrative: Patient TC-patient

Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)


Contact Detail
  • ph: tel:+41.32.685.12.34(Home)
  • Leidensweg 10 Specimendorf 9876 CH

Entry 3 - fullUrl = http://test.fhir.ch/r4/Practitioner/TC-HCP1-C1

Resource Practitioner:

Generated Narrative: Practitioner TC-HCP1-C1

identifier: GLN/7601888888884

active: true

name: Peter Müller

telecom: ph: tel:+41.32.234.55.66(Work), fax: fax:+41.32.234.55.67(Work), mailto:allzeit.bereit@gruppenpraxis.ch, http://www.gruppenpraxis.ch

address: Grabenstrasse 2 Zürich 8005 CH


Entry 4 - fullUrl = http://test.fhir.ch/r4/Organization/TC-ORG1

Resource Organization:

Generated Narrative: Organization TC-ORG1

identifier: GLN/7601777777718

name: Gruppenpraxis Müller

contact

telecom: ph: tel:+41.32.234.55.66(Work), fax: fax:+41.32.234.55.67(Work), mailto:bereit@gruppenpraxis.ch, http://www.gruppenpraxis.ch

address: Grabenstrasse 2 Zürich ZH 8005 CH


Entry 5 - fullUrl = http://test.fhir.ch/r4/PractitionerRole/TC-HCP1-ORG1-ROLE-performer

Resource PractitionerRole:

Generated Narrative: PractitionerRole TC-HCP1-ORG1-ROLE-performer

active: true

practitioner: Practitioner Peter Müller

organization: Organization Gruppenpraxis Müller


Entry 6 - fullUrl = http://test.fhir.ch/r4/Immunization/TCC01-IMMUN1-patient

Resource Immunization:

Generated Narrative: Immunization TCC01-IMMUN1-patient

Author of the content: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)

CH VACD Extension Immunization Medication Reference: Medication HAVRIX 1440 Inj Susp

Entry Resource Cross References

  • entry: Identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1/acc1f090-5e0c-45ae-b283-521d57c3aa2f
  • container: Identifier: URI/urn:uuid:b505b90a-f241-41ca-859a-b55a6103e753
  • relationcode: replaces

identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1/375532dc-7e74-40dd-8564-3261e8d26603

status: Completed

vaccineCode: Havrix 1440

lotNumber: AHAVB946A

patient: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)

occurrence: 2021-06-02

route: Intramuscular use

Performers

-Actor
*PractitionerRole

ProtocolApplieds

-TargetDisease
*Viral hepatitis, type A (disorder)

Entry 7 - fullUrl = http://test.fhir.ch/r4/Medication/TC-IMMUN-MEDIC-HAVRIX1440

Resource Medication:

Generated Narrative: Medication TC-IMMUN-MEDIC-HAVRIX1440

identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1/359000dc-2cee-4a6e-ab05-577f558840e2

code: HAVRIX 1440 Inj Susp

status: Active

ingredient

Batches

-LotNumber
*AHAVB946A

Entry 8 - fullUrl = http://test.fhir.ch/r4/Organization/TC-ORG-GSK

Resource Organization:

Generated Narrative: Organization TC-ORG-GSK

identifier: GLN/7601001000674

name: GlaxoSmithKline AG

contact

telecom: ph: tel:+41 31 862 21 11(Work), fax: fax:+41 31 862 22 00(Work), mailto:swiss.info@gsk.com, https://www.gsk.com

address: Talstrasse 3-5 Münchenbuchsee BE 3053 CH